Skip to main content

11 Result(s)

within A Traynor Remove this filter

and

  1. Article

    Open Access

    An analysis of emerging food safety and fraud risks of novel insect proteins within complex supply chains

    Food consumption play a crucial role in human life, yet conventional food production and consumption patterns can be detrimental to the environment. Thus, research and development has been directed towards alt...

    A. Traynor, D. Thorburn Burns, D. Wu, N. Karoonuthaisiri… in npj Science of Food (2024)

    Download PDF (1675 KB) View Article

  2. No Access

    Article

    Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus patients with cardiac dysfunction: feasibility and reversibility of ventricular and valvular dysfunction with transplant-induced remission

    Patients with cardiac dysfunction may be at increased risk of cardiac toxicity when undergoing hematopoietic stem cell transplantation (HSCT), which may preclude them from receiving this therapy. Cardiac dysfu...

    Y Loh, Y Oyama, L Statkute, A Traynor, J Satkus, K Quigley… in Bone Marrow Transplantation (2007)

  3. No Access

    Article

    Mobilization, harvesting and selection of peripheral blood stem cells in patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation

    Peripheral blood stem cells (PBSC) were mobilized in 130 patients with autoimmune diseases undergoing autologous hematopoietic stem cell transplantation using cyclophosphamide 2 g/m2 and either granulocyte colony...

    L Statkute, L Verda, Y Oyama, A Traynor, M Villa, T Shook… in Bone Marrow Transplantation (2007)

  4. Article

    The rationale behind autologous autoimmune hematopoietic stem cell transplant conditioning regimens: concerns over the use of total-body irradiation in systemic sclerosis

    Hematopoietic stem cell transplantation (HSCT) is becoming an increasingly recognized indication for treatment of autoimmune diseases and severe immune-mediated disorders. However, multicenter registry data ha...

    R K Burt, K Kallunian, D Patel, J Thomas, A Yeager… in Bone Marrow Transplantation (2004)

    Download PDF (142 KB) View Article

  5. No Access

    Article

    Hematopoietic stem cell transplantation for systemic sclerosis with rapid improvement in skin scores: is neoangiogenesis occurring?

    Systemic sclerosis (SSc) is presumed to be an immune-mediated vasculopathy of unknown etiology. SSc is unresponsive to most immune-modulating therapies except for intravenous cyclophosphamide, which is reporte...

    R K Burt, Yu Oyama, A Traynor, K Quigley, M Brush… in Bone Marrow Transplantation (2003)

  6. No Access

    Article

    Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus

    At Northwestern University, a phase I/II trial of hematopoietic stem cell transplant (HSCT) for systemic lupus erythematosus (SLE) has shown promising results. A phase III HSCT trial is being developed to conf...

    R K Burt, A Marmont, R Arnold, F Heipe, G S Firestein… in Bone Marrow Transplantation (2003)

  7. No Access

    Article

    Hematopoietic stem cell transplantation for severe Crohn's disease

    It is clear that some patients with severe Crohn's disease (CD) fail to respond favorably to the standard treatment, including antibody to Tumor Necrosis Factor alpha (TNFα), We have embarked on a unique thera...

    R M Craig, A Traynor, Y Oyama, R K Burt in Bone Marrow Transplantation (2003)

  8. No Access

    Article

    Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program

    Our goal was to compare direct and indirect medical costs and quality of life associated with inpatient vs outpatient autologous hematopoietic stem cell transplantation (AuHSCT). Twenty-one sequential outpatients...

    P Frey, T Stinson, A Siston, SJ Knight, E Ferdman, A Traynor… in Bone Marrow Transplantation (2002)

  9. No Access

    Article

    Engraftment syndrome: a common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis

    Autologous hematopoietic stem cell transplantation (HSCT) is currently being evaluated as a therapy for patients with progressive multiple sclerosis (MS) at risk of debilitating neurological impairment. While ...

    Y Oyama, B Cohen, A Traynor, M Brush, J Rodriguez, RK Burt in Bone Marrow Transplantation (2002)

  10. No Access

    Article

    CD34+ cell collection efficiency does not correlate with the pre-leukapheresis hematocrit

    One hundred and seventy-seven large-volume leukapheresis procedures performed on 91 patients over a 15 month period were reviewed to see if the pre-apheresis hematocrit (Hct) affected the CD34+ cell collection ef...

    J Mehta, Y Oyama, J Winter, S Williams, M Tallman, S Singhal… in Bone Marrow Transplantation (2001)

  11. No Access

    Article

    Allogeneic hematopoietic stem cell transplantation for advanced mycosis fungoides: evidence of a graft-versus-tumor effect

    Allogeneic hematopoietic stem cell transplantation should be considered as a therapeutic option for patients with generalized erythoderma or tumor stage MF. Indeed, the only curative option for MF may be an al...

    RK Burt, J Guitart, A Traynor, C Link, S Rosen, T Pandolfino… in Bone Marrow Transplantation (2000)